Japanese Diversified Financial Stock News

Earnings snapshot and why this matters for NEC shareholders NEC (TSE:6701) has drawn fresh attention after reporting full year results to 31 March 2026, with sales of ¥3,582,733 million and net income of ¥270,228 million, alongside higher basic and diluted EPS from continuing operations. For existing and potential shareholders, these figures give an updated view of how NEC is converting its information technology and social infrastructure business into earnings, and how each share is...

Mitsui O.S.K. Lines, Ltd. ( TSE:9104 ) just released its yearly report and things are looking bullish. Results were...

Nihon M&A Center Holdings Inc. ( TSE:2127 ) just released its latest annual results and things are looking bullish. The...

It's been a good week for East Japan Railway Company ( TSE:9020 ) shareholders, because the company has just released...

As you might know, Kyocera Corporation ( TSE:6971 ) just kicked off its latest yearly results with some very strong...

HOYA Corporation ( TSE:7741 ) shareholders are probably feeling a little disappointed, since its shares fell 2.7% to...

ANA Holdings Inc. ( TSE:9202 ) last week reported its latest yearly results, which makes it a good time for investors...

Hokkaido Electric Power Company, Incorporated held a board meeting on April 28, 2026 to consider a notice regarding an increase in the year-end dividend from surplus. This focus on dividend policy is material for investors because shifts in payout decisions can reshape how the company’s capital allocation priorities are perceived. We will now examine how the potential year-end dividend increase could influence Hokkaido Electric Power’s broader investment narrative and appeal. We've uncovered...

On April 27, 2026, Shin-Etsu Polymer Co., Ltd. reported full-year results for the period ended March 31, 2026, posting sales of ¥115,116 million and net income of ¥9,899 million, alongside basic earnings per share of ¥123.15 and diluted earnings per share of ¥122.28. At the same board meeting, the company moved to consider revising its dividend forecast for the fiscal year ending March 31, 2026, highlighting how earnings outcomes may influence its future shareholder payout policy. With the...

Why Advantest’s latest earnings matter for shareholders Advantest (TSE:6857) just reported full year sales of ¥1,128,610 million and net income of ¥375,353 million for the period to March 2026, alongside fresh product and partnership updates tied to AI and high performance computing. See our latest analysis for Advantest. Despite a 1-day share price return of 1.57% decline and a 7-day share price return of 5.52% decline, Advantest’s 30-day share price return of 31.67% and very large 1-year...

Canon Marketing Japan (TSE:8060) is back on investors’ radar after its Q1 2026 results, reporting higher sales, net income, and earnings per share, along with full year guidance and dividend plans for 2026. See our latest analysis for Canon Marketing Japan. The stock’s 1 day share price return of 1.45% came after the Q1 earnings release. The 30 day and 90 day share price returns of 5.04% and 7.63% point to building momentum on top of a 47.45% 1 year total shareholder return. If Canon...

KDDI (TSE:9433) received a compliance and governance improvement order from the Tokyo Stock Exchange. The exchange also issued a listing rule violation penalty related to KDDI's governance and compliance practices. KDDI issued a public apology and stated it will strengthen governance and introduce measures to prevent a repeat of the issue. KDDI, a major Japanese telecom operator, sits at the center of mobile, broadband, and enterprise connectivity, where reliability and regulatory...

DENSO, ticker TSE:6902, is reportedly considering withdrawing its acquisition proposal for power semiconductor maker ROHM. The potential withdrawal follows ROHM’s move to explore an integration with Toshiba and Mitsubishi Electric. This development affects earlier expectations around consolidation in Japan’s power semiconductor sector. DENSO is a major auto parts supplier with a growing focus on power semiconductors, which are used in electric vehicles, advanced driver assistance systems...

If you are wondering whether Mazda Motor's current share price still offers value, it helps to step back and look at what the recent returns and fundamentals are really telling you. The stock last closed at ¥1,008.5, with a 1.5% decline over the past week and a 3.5% decline over the past month, while still showing a 21.4% return over the past year and 40.4% over five years. Recent coverage has focused on Mazda Motor's share price performance over different time frames, highlighting the...

Shimizu Corporation recently raised its consolidated and non-consolidated earnings guidance for the fiscal year ending March 31, 2026, projecting net sales of ¥2.06 billion and higher operating and net income, supported by stronger domestic construction activity and an expected special gain from acquiring Aomi Construction as a subsidiary. The company also lifted its full-year dividend forecast to ¥50.00 per share, signaling management’s confidence in the improved profitability of its...

Astellas Pharma Inc. recently reported full-year results to March 31, 2026, with sales rising to ¥2.14 trillion and net income to ¥291.54 billion, alongside an FDA Priority Review for a broader PADCEV plus Keytruda indication in muscle-invasive bladder cancer. Together with upcoming retinal-disease data presentations and board-level changes under consideration, these developments underscore how oncology and ophthalmology innovation are increasingly central to Astellas’ business mix. We’ll...

SoftBank Group (TSE:9984) is back in focus after outlining Roze, a new AI and robotics venture planned for a high profile U.S. IPO, alongside securing a US$40b loan earmarked for OpenAI investment. See our latest analysis for SoftBank Group. Those Roze and OpenAI moves come after a sharp 50.5% 30 day share price return, helping SoftBank Group reach a ¥5,424 share price, while the 1 year total shareholder return of 193.7% signals strong longer term momentum. If the AI theme around Roze has...

Seiko Epson (TSE:6724) has put out a solidly detailed FY 2026 update, with third quarter revenue at ¥376.5 billion and basic EPS at ¥52.37, while trailing 12 month figures show revenue at about ¥1.38 trillion and EPS at ¥134.84. Over recent periods the company has seen revenue move from ¥339.1 billion in Q4 FY 2025 to ¥376.5 billion in Q3 FY 2026, with quarterly EPS shifting from ¥24.56 to ¥52.37 as net income moved from ¥7,798 million to ¥16,781 million over the same stretch. For investors,...

With inflation pressures, tighter central bank policy and mixed growth signals across major economies, many investors are looking for companies that can keep compounding value without depending on easy money or booming demand. A focus on high return on equity, solid past performance and strong balance sheets can help concentrate on businesses that have already shown they can turn every dollar of capital into meaningful profits while keeping debt in check. This article highlights 3 stocks from...

It's been a mediocre week for CUC Inc. ( TSE:9158 ) shareholders, with the stock dropping 18% to JP¥776 in the week...

It's been a pretty great week for Kandenko Co.,Ltd. ( TSE:1942 ) shareholders, with its shares surging 11% to JP¥6,734...

It's been a pretty great week for NGK Corporation ( TSE:5333 ) shareholders, with its shares surging 16% to JP¥5,121 in...

Sumitomo (TSE:8053) has laid out its FY 2026 scorecard with third quarter revenue of about ¥1.8 trillion and basic EPS of ¥89.49, set against a trailing twelve month revenue base of roughly ¥7.4 trillion and EPS of ¥458.92 that highlight how much earnings power it has put together over the past year. The company has seen quarterly revenue range from around ¥1.75 trillion to ¥1.98 trillion since FY 2025 Q2, while EPS has moved between ¥89.49 and ¥141.26, giving investors a clear view of how...

Asahi Kasei (TSE:3407) has drawn fresh attention after starting a Phase I clinical trial for AK1940, a peptide-based autoimmune drug candidate that management links to its medium-term pharmaceutical growth plans. See our latest analysis for Asahi Kasei. The AK1940 trial and recent bond shelf registration activity come as Asahi Kasei’s share price trades at ¥1,524.5, with a 1-year total shareholder return of 55.53% and 3-year total shareholder return of 75.92%. This suggests momentum has been...